EHA 2019: Overcoming the “Don’t Eat Me” signal of refractory lymphomas
Chemotherapy for non-Hodgkin’s lymphomas is highly effective for most patients. In aggressive lymphomas, such as…
Browsing: Lymphoma
Researchers pinpoint why lymphoma patients may become resistant to specific therapy
With more targeted therapies being approved each year for cancer, the development of drug resistance…
New drug effective in overcoming ibrutinib resistance in mantle cell lymphoma
A study at The University of Texas MD Anderson Cancer Center demonstrated how a small…
Radiotherapy after chemotherapy may improve survival for patients with advanced Hodgkin’s lymphoma
Patients with advanced Hodgkin’s lymphoma who have large tumours at the time of diagnosis may…
Vaccination against Epstein-Barr virus might reduce the risk of developing Hodgkin’s lymphoma, study suggests
Cells of certain blood cancers such as Hodgkin’s lymphoma carry the protein CD30 on their…
AACR 2019: Single agent umbralisib effective for relapsed slow-growing lymphoma
A study at The University of Texas MD Anderson Cancer Center revealed the investigational drug…
Treatment guidelines for breast implant-associated lymphoma (BIA-ALCL)
The use of textured breast implants during augmentation or reconstructive surgery can slightly increase a…
Exposure to chemical in Roundup increases risk for cancer: study
Exposure to glyphosate—the world’s most widely used, broad-spectrum herbicide and the primary ingredient in the…
Scientists learn how common virus reactivates after transplantation
A new study in Science challenges long-held theories of why a common virus—cytomegalovirus, or CMV—can reactivate and…
Survivors of childhood Hodgkin lymphoma face high long-term risk of solid cancers
New research refines existing evidence that survivors of childhood Hodgkin lymphoma face an elevated risk…